The insider selling is immaterial relative to market cap and lacks a bearish catalyst. No cross-filing context (earnings, late filing, or agreement) amplifies the signal. Monitor for any upcoming regulatory or pipeline catalysts, but this cluster alone does not warrant a trading action.
Price Chart
Executive Summary
Three PTC Therapeutics insiders, including the CFO and Chief Technical Ops Officer, sold a total of $1.40M in stock over a one-week window. The sales are modest relative to the $6.5B market cap (0.02%) and are likely driven by routine portfolio diversification or tax planning, not a bearish signal on fundamentals. The cluster is not amplified by any material cross-filing context such as earnings or a late filing, and the historical calibration shows this type of report has a neutral-to-positive track record on PTCT.
Key Financial Metrics
Key Facts
- Three insiders sold shares totaling $1.40M between July 7-14, 2026.
- CFO Pierre Gravier sold 3,494 shares at $80.35 for $280,743.
- Chief Technical Ops Officer Neil Almstead sold 2,500 shares at $90.25 for $222,000.
- Director Mary L. Smith sold 10,000 shares at $90.00 for $900,000.
- Total sales represent approximately 0.02% of PTCT's $6.5B market cap.
- No open-market purchases were reported in the cluster.
Financial Impact
Total insider sales of $1.40M represent 0.02% of market cap — trivial and routine.
Risk Factors
- Insider sales could accelerate if a negative catalyst emerges (e.g., clinical trial failure, regulatory setback).
- The CFO's sale at a lower price ($80.35) than the other two ($90.00-$90.25) may indicate a staggered exit, but the difference is within normal trading range.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PTCT-1784275361376 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 6w ago | Insider Cluster | $69.82 $65.26 | ▼ −6.53% | ▼ −6.00% | $63.46 (−9.11%) |
Jul 16, 2026 11w ago | Press Release | $78.52 $71.97 | ▲ +8.34% | ▲ +11.96% | $63.46 (+19.18%) |
Jul 16, 2026 11w ago | Insider Cluster | $78.52 $71.97 | ▼ −8.34% | ▼ −11.96% | $63.46 (−19.18%) |
Jul 13, 2026 11w ago | Insider Cluster | $81.33 $74.63 | ▼ −8.24% | ▼ −11.42% | $63.46 (−21.97%) |
Jul 8, 2026 12w ago | Insider Cluster | $88.57 $69.21 | ▼ −21.86% | ▼ −25.13% | $63.46 (−28.35%) |
Jun 26, 2026 14w ago | Insider Cluster | $81.57 $76.82 | ▼ −5.82% | ▼ −5.54% | $63.46 (−22.20%) |
Jun 16, 2026 15w ago | 8-K | $73.27 $78.06 | ▲ +6.54% | ▲ +6.34% | $63.46 (−13.39%) |
Jun 9, 2026 16w ago | 8-K | $73.35 $89.55 | ▲ +22.09% | ▲ +18.46% | $63.46 (−13.48%) |
May 19, 2026 19w ago | Insider Cluster | $71.02 $78.98 | ▲ +11.21% | ▲ +10.47% | $63.46 (−10.64%) |
May 15, 2026 20w ago | Insider Cluster | $70.15 $73.27 | ▲ +4.45% | ▲ +2.87% | $63.46 (−9.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access